Your Flagship ADC Event in Europe
Your Preliminary Agenda Is Here - View It Now

Expanding ADC Use Across Tumour Types & Patient Populations for Difficult to Treat Solid Tumours Including Pancreatic, Glioblastoma, and Sarcomas

Expanding ADC Use Across Tumour Types & Patient Populations for Difficult to Treat Solid Tumours Including Pancreatic, Glioblastoma, and Sarcomas

2:15 pm - Wednesday 10th March 2027

Developing stage-appropriate bioanalytical strategies for conventional and dual-payload ADCs
Using clinical case studies to inform ADC immunogenicity assessment across indications and development stages
Applying science- and risk-based approaches to dual-payload ADCs and combinations

Speakers:

Lakshmi Amaravadi

Head of Oncology Bioanalytical Strategy Team, Clinical Pharmacology & Safety Sciences

AstraZeneca